* Biomerieux receives FDA clearance for expanded use of
VIDAS B.R.A.H.M.S PCT test for managing sepsis patients with
elevated risk of mortality
Source text for Eikon:
Further company coverage:
…
The post BRIEF-Biomerieux gets FDA clearance for VIDAS B.R.A.H.M.S PCT test appeared first on NASDAQ.